AVDL - Avadel Pharmaceuticals EPS beats by $0.21 beats on revenue May, 11 2020 07:06 AM Avadel Pharmaceuticals plc Avadel Pharmaceuticals (NASDAQ:AVDL): Q1 GAAP EPS of -$0.02 beats by $0.21.More news on: Avadel Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news, Read more ...